Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07287085Not ApplicableRecruiting

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

Role: collaborator

NCT04347161Not ApplicableActive Not Recruiting

Implementation Strategies for Monitoring Adherence in Real Time

Role: collaborator

NCT04712877Recruiting

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

Role: collaborator

NCT03919864Not ApplicableCompleted

Connect Oncology Needs Evaluation Tool

Role: collaborator

NCT02755883Not ApplicableCompleted

Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients

Role: collaborator

All 5 trials loaded